These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35716975)

  • 1. Development of a novel method for the continuous blending of carrier-based dry powders for inhalation using a co-rotating twin-screw extruder.
    Spahn JE; Hefnawy A; Smyth HDC; Zhang F
    Int J Pharm; 2022 Jul; 623():121914. PubMed ID: 35716975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twin-Screw Continuous Mixing Can Produce Dry Powder Inhalation Mixtures for Pulmonary Delivery.
    Ren A; Koleng JJ; Costello M; Spahn JE; Smyth HDC; Zhang F
    J Pharm Sci; 2023 Jan; 112(1):272-281. PubMed ID: 36228755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry Powder Mixing Is Feasible in Continuous Twin Screw Extruder: Towards Lean Extrusion Process for Oral Solid Dosage Manufacturing.
    Mateo-Ortiz D; Villanueva-Lopez V; Muddu SV; Doddridge GD; Alhasson D; Dennis MC
    AAPS PharmSciTech; 2021 Oct; 22(7):249. PubMed ID: 34648107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in lactose blend formulations for carrier-based dry powder inhalation.
    Hebbink GA; Jaspers M; Peters HJW; Dickhoff BHJ
    Adv Drug Deliv Rev; 2022 Oct; 189():114527. PubMed ID: 36070848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of high shear blending on distribution of magnesium stearate on lactose for dry powder inhaled formulations.
    Welle A; Mehta M; Marek K; Peters H; van der Wel P; Imole O
    Int J Pharm; 2023 Nov; 647():123503. PubMed ID: 37827391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixing of dry powders for inhalation: A review.
    Spahn JE; Zhang F; Smyth HDC
    Int J Pharm; 2022 May; 619():121736. PubMed ID: 35405281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers.
    Lucas P; Anderson K; Staniforth JN
    Pharm Res; 1998 Apr; 15(4):562-9. PubMed ID: 9587952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mixing on the dispersibility of adhesive mixtures for inhalation. Comparison of high shear and Turbula mixers.
    Thalberg K; Ivarsson L; Svensson M; Elfman P; Ohlsson A; Stuckel J; Lyberg AM
    Eur J Pharm Sci; 2024 Feb; 193():106679. PubMed ID: 38128841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.
    Zeng XM; Pandhal KH; Martin GP
    Int J Pharm; 2000 Mar; 197(1-2):41-52. PubMed ID: 10704792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend.
    Wauthoz N; Hennia I; Ecenarro S; Amighi K
    Int J Pharm; 2018 Dec; 553(1-2):47-56. PubMed ID: 30321640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of surface coating with magnesium stearate via mechanical dry powder coating approach on the aerosol performance of micronized drug powders from dry powder inhalers.
    Zhou QT; Qu L; Gengenbach T; Larson I; Stewart PJ; Morton DA
    AAPS PharmSciTech; 2013 Mar; 14(1):38-44. PubMed ID: 23196863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-milled API-lactose systems for inhalation therapy: impact of magnesium stearate on physico-chemical stability and aerosolization performance.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Jun; 43(6):980-988. PubMed ID: 28122460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
    Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
    Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance.
    Bosquillon C; Lombry C; Préat V; Vanbever R
    J Control Release; 2001 Feb; 70(3):329-39. PubMed ID: 11182203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of surface layering time of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K; Hayakawa Y; Okamoto H; Danjo K; Luenberger H
    Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):350-3. PubMed ID: 14993760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier.
    Iida K; Hayakawa Y; Okamoto H; Danjo K; Luenberger H
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):444-6. PubMed ID: 15056961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the role of particle morphology in pharmaceutical powder aerosols?
    Chan HK
    Expert Opin Drug Deliv; 2008 Aug; 5(8):909-14. PubMed ID: 18712999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug.
    Sethuraman VV; Hickey AJ
    AAPS PharmSciTech; 2002; 3(4):E28. PubMed ID: 12916922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.